These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9686771)

  • 61. Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons.
    Jami MS; Pal R; Hoedt E; Neubert TA; Larsen JP; Møller SG
    BMC Neurosci; 2014 Jul; 15():93. PubMed ID: 25082231
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress.
    Gélinas S; Bureau G; Valastro B; Massicotte G; Cicchetti F; Chiasson K; Gagne B; Blanchet J; Martinoli MG
    Neurotox Res; 2004; 6(2):141-8. PubMed ID: 15325966
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress.
    Baratchi S; Kanwar RK; Kanwar JR
    PLoS One; 2011 Jan; 6(1):e15865. PubMed ID: 21249229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reversible and irreversible oxidant injury to PC12 cells by hydrogen peroxide.
    Halleck MM; Richburg JH; Kauffman FC
    Free Radic Biol Med; 1992; 12(2):137-44. PubMed ID: 1559617
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Structural-functional study of glycine-and-proline-containing peptides (glyprolines) as potential neuroprotectors].
    Martynova KV; Andreeva LA; Klimova PA; Kirillova IuG; Shevchenko VP; Nagaev IIu; Shram IIu; Shvets VI; Miasoedov NF
    Bioorg Khim; 2009; 35(2):165-71. PubMed ID: 19537167
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants.
    dos Santos El-Bachá R; Daval J; Koziel V; Netter P; Minn A
    Biochem Pharmacol; 2001 Jan; 61(1):73-85. PubMed ID: 11137712
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dose-dependent induction of apoptosis by R-apomorphine in CHO-K1 cell line in culture.
    Pardini C; Vaglini F; Galimberti S; Corsini GU
    Neuropharmacology; 2003 Aug; 45(2):182-9. PubMed ID: 12842124
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells: protection by bovine serum albumin and formation of apomorphine-protein conjugates.
    El-Bachá RS; Netter P; Minn A
    Neurosci Lett; 1999 Mar; 263(1):25-8. PubMed ID: 10218902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism.
    Sam EE; Verbeke N
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):115-27. PubMed ID: 9620059
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Conformational analysis and geometry optimization of apomorphine as an Anti-parkinsonian agen.
    Ikram H; Bano K; Jameel M; Azhar M; Saeed K; Sufian M
    Pak J Pharm Sci; 2015 Sep; 28(5):1685-90. PubMed ID: 26408888
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells.
    Maggio R; Armogida M; Scarselli M; Salvadori F; Longoni B; Pardini C; Chiarenza A; Chiacchio S; Vaglini F; Bernardini R; Colzi A; Corsini GU
    Neurotox Res; 2000 Apr; 1(4):285-97. PubMed ID: 12835096
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Free radical and lipid peroxidation in manganese-induced neuronal cell injury.
    Sun AY; Yang WL; Kim HD
    Ann N Y Acad Sci; 1993 May; 679():358-63. PubMed ID: 8512199
    [No Abstract]   [Full Text] [Related]  

  • 73. Preliminary observations on the in vitro toxicity of N-butylbenzenesulfonamide: a newly discovered neurotoxin.
    Nerurkar VR; Wakayama I; Rowe T; Yanagihara R; Garruto RM
    Ann N Y Acad Sci; 1993 May; 679():280-7. PubMed ID: 8512189
    [No Abstract]   [Full Text] [Related]  

  • 74. Toxicity of sulphur-containing compounds to neuronal cell lines.
    Pean AR; Parsons RB; Waring RH; Williams AC; Ramsden DB
    J Neurol Sci; 1995 May; 129 Suppl():107-8. PubMed ID: 7595598
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retraction: PKM2 overexpression protects against 6-hydroxydopamine-induced cell injury in the PC12 cell model of Parkinson's disease
    Fisher L
    RSC Adv; 2021 Jan; 11(9):5020. PubMed ID: 35427044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Near-Infrared Fluorogenic Probe for Rapid, Specific, and Ultrasensitive Detection of Sphingosine in Living Cells and In Vivo.
    Chen Y; Hao T; Wang J; Chen Y; Wang X; Wei W; Zhao J; Qian Y
    Adv Sci (Weinh); 2024 Jan; 11(2):e2307598. PubMed ID: 38032131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.
    Auffret M; Drapier S; Vérin M
    Clin Drug Investig; 2018 Apr; 38(4):287-312. PubMed ID: 29327219
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of apomorphine in the treatment of Parkinson's disease.
    Boyle A; Ondo W
    CNS Drugs; 2015 Feb; 29(2):83-9. PubMed ID: 25676564
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apomorphine and Alzheimer Aβ: roles for regulated α cleavage, autophagy, and antioxidation?
    Steele JW; Gandy S
    Ann Neurol; 2011 Feb; 69(2):221-5. PubMed ID: 21387363
    [No Abstract]   [Full Text] [Related]  

  • 80. A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A.
    Fishman-Jacob T; Reznichenko L; Youdim MB; Mandel SA
    J Biol Chem; 2009 Nov; 284(47):32835-45. PubMed ID: 19748892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.